Zomedica to Spotlight VETGuardian(R) Zero Touch(TM) Monitor in October "Fourth Friday at Four" Webinar

Live session on October 24th will showcase how the VETGuardian Monitor enhances patient care, improves workflow efficiency, and expands global market opportunities

ANN ARBOR, MI / ACCESS Newswire / October 9, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering innovative point-of-care diagnostic and therapeutic device products for equine and companion animals, today announced that its upcoming "Fourth Friday at Four" webinar series, to be held on October 24, 2025 at 4:00 p.m. ET, will feature a deep dive into Zomedica's VETGuardian Zero Touch monitoring platform.

Key Learning Points

• Market Expansion Opportunity: The veterinary monitoring market is projected to reach $720 million in 2025, growing at ~8% annually through 2029, creating a sizable addressable market for the VETGuardian monitor.

  • Differentiated Technology: The VETGuardian monitor is the only Zero Touch solution offering continuous monitoring without wires or contact, improving animal welfare and clinical workflow efficiency.

  • Strengthened Portfolio Value: The VETGuardian monitor adds a high-growth technology to Zomedica's expanding platform of gold-standard therapeutics and advanced diagnostics, creating multiple revenue streams.

The October 24th webinar will highlight how the VETGuardian monitor is reshaping veterinary monitoring through its pioneering Zero Touch approach. Unlike traditional systems that require wires or contact devices, the VETGuardian monitor leverages advanced radar and imaging technology to continuously capture patient vital signs, heart rate, respiration, and body temperature, all without physical contact. This innovation reduces patient stress, enhances safety for veterinary teams, and provides ongoing monitoring for critical cases.

With broader adoption of telemedicine and growing demand for personalized pet care, Zomedica believes the VETGuardian monitor represents not only a clinical advancement but also a significant growth driver in the veterinary monitoring market.

The Fourth Friday at Four webinars are designed to connect Zomedica directly with veterinarians, investors, and stakeholders, offering educational insight into the Company's expanding portfolio of innovative diagnostic and therapeutic technologies. The October 24th session will be available via live webcast, with details and registration accessible on the Company's website.